News | October 03, 2007

93 Percent of AFib Magnetic Navigation Treatments Successful

October 4, 2007 – The acute success rate in patients treated for atrial fibrillation with the Niobe magnetic navigation system by Stereotaxis was 93 percent, announced Xu Chen, M.D., of the Rigshospitalet at the University of Copenhagen who presented the data at the recent European Society of Cardiology Congress (ESC) in Vienna.

Dr. Chen’s presentation focused on his use of catheter ablation to treat 42 patients with atrial fibrillation. In all cases, Dr. Chen guided the catheters with the Niobe magnetic navigation system, controlled from his remote station adjacent to the procedure room. In 93 percent of these cases the pulmonary veins were reportedly fully isolated from the left atrium, eliminating the main cause of the arrhythmia.

The magnetic fields and computer guidance system is designed to be capable of very precise and accurate movements in the most sensitive areas of the heart, and of maintaining the catheter’s consistent contact with the beating heart’s surface. This consistent contact allows the physician to deliver ablation energy safely and effectively to treat a broad range of arrhythmias.

For more information: www.stereotaxis.com


Related Content

News

Oct. 24, 2024 — Medtronic plc has announced United States Food and Drug Administration (FDA) approval of the Affera ...

Home October 30, 2024
Home
News

Oct. 18, 2024 — Boston Scientific Corp. recently announced it has received U.S. Food and Drug Administration (FDA) ...

Home October 21, 2024
Home
News

May 15, 2024 —CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac ...

Home May 15, 2024
Home
News

May 13, 2024 — Innovative Health, Inc. announced that recent growth in single-use device reprocessing has delivered ...

Home May 13, 2024
Home
News

October 10, 2023 — Axon Therapies, a private company focused on addressing a root cause of heart failure, announced 6 ...

Home October 10, 2023
Home
News

August 9, 2023 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration (FDA) ...

Home August 09, 2023
Home
News

January 31, 2023 —Imricor, a global leader in real-time interventional cardiac magnetic resonance (iCMR) ablation ...

Home January 31, 2023
Home
News

December 21, 2022 — Stereotaxis, a global leader in robotic technologies for the treatment of cardiac arrhythmias ...

Home December 21, 2022
Home
News

October 24, 2022 — Acutus Medical, Inc, an arrhythmia management company focused on improving the way cardiac ...

Home October 24, 2022
Home
News

May 13, 2022 — Acutus Medical, an arrhythmia management company focused on improving the way cardiac arrhythmias are ...

Home May 13, 2022
Home
Subscribe Now